Zhang, L.; Sun, J.; Wang, K.; Zhao, H.; Zhang, X.; Ren, Z.
First- and Second-Line Treatments for Patients with Advanced Hepatocellular Carcinoma in China: A Systematic Review. Curr. Oncol. 2022, 29, 7305-7326.
https://doi.org/10.3390/curroncol29100575
AMA Style
Zhang L, Sun J, Wang K, Zhao H, Zhang X, Ren Z.
First- and Second-Line Treatments for Patients with Advanced Hepatocellular Carcinoma in China: A Systematic Review. Current Oncology. 2022; 29(10):7305-7326.
https://doi.org/10.3390/curroncol29100575
Chicago/Turabian Style
Zhang, Lan, Junhui Sun, Kui Wang, Haitao Zhao, Xijie Zhang, and Zhenggang Ren.
2022. "First- and Second-Line Treatments for Patients with Advanced Hepatocellular Carcinoma in China: A Systematic Review" Current Oncology 29, no. 10: 7305-7326.
https://doi.org/10.3390/curroncol29100575
APA Style
Zhang, L., Sun, J., Wang, K., Zhao, H., Zhang, X., & Ren, Z.
(2022). First- and Second-Line Treatments for Patients with Advanced Hepatocellular Carcinoma in China: A Systematic Review. Current Oncology, 29(10), 7305-7326.
https://doi.org/10.3390/curroncol29100575